Andrea Sacconi
Overview
Explore the profile of Andrea Sacconi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
1764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scafetta G, Rampioni Vinciguerra G, Giglio S, Faruq O, Cirombella R, Segatto I, et al.
J Exp Clin Cancer Res
. 2025 Mar;
44(1):96.
PMID: 40082972
Breast cancer ranks as the most prevalent form of cancer globally. Currently, advanced screening methods have significantly improved early detection rates. These achievements have led to more non-invasive cancer diagnoses...
2.
Valenti F, Ganci F, Sacconi A, Lo Sardo F, DAndrea M, Sanguineti G, et al.
J Mol Med (Berl)
. 2024 Oct;
102(12):1485-1501.
PMID: 39480521
Polo-like kinase 2 (Plk2) belongs to a family of serine/threonine kinases, and it is involved in tumorigenesis of diverse kind of tissues. We previously reported that Plk2 gene was a...
3.
Lo Sardo F, Turco C, Messina B, Sacconi A, Auciello F, Pulito C, et al.
Cell Death Discov
. 2024 Oct;
10(1):452.
PMID: 39455556
The tumor suppressor PTEN (phosphatase and tensin homolog deleted in chromosome 10) is genetically deleted or downregulated in many cancer types. Loss of PTEN protein expression is frequently found in...
4.
Piastra V, Ganci F, Sacconi A, Pranteda A, Allegretti M, Bernardini R, et al.
J Exp Clin Cancer Res
. 2024 Aug;
43(1):234.
PMID: 39164711
Background: Colorectal cancer (CRC) is the third most common type of cancer and the second leading cause of cancer-related deaths worldwide, with a survival rate near to 10% when diagnosed...
5.
Canu V, Vaccarella S, Sacconi A, Pulito C, Goeman F, Pallocca M, et al.
Cell Death Dis
. 2024 Aug;
15(8):603.
PMID: 39164278
Triple negative breast cancer (TNBC) is an aggressive disease which currently has no effective therapeutic targets and prominent biomarkers. The Sperm Associated antigen 5 (SPAG5) is a mitotic spindle associated...
6.
Tocci P, Roman C, Sestito R, Caprara V, Sacconi A, Molineris I, et al.
Clin Sci (Lond)
. 2024 Jun;
138(14):851-862.
PMID: 38884602
The high-grade serous ovarian cancer (HG-SOC) tumor microenvironment (TME) is constellated by cellular elements and a network of soluble constituents that contribute to tumor progression. In the multitude of the...
7.
Nuvoli B, Sacconi A, Bottillo G, Sciarra F, Libener R, Maconi A, et al.
Biomed Pharmacother
. 2024 May;
175:116662.
PMID: 38692064
17-β-estradiol, involved in mesothelioma pathogenesis, and its precursors were explored as potential biomarkers for the early diagnosis of mesothelioma. Using enzyme-linked immunosorbent assay(ELISA) for 17-β-estradiol and ultra-high performance liquid chromatography/tandem...
8.
Ganci F, Allegretti M, Frascolla C, Spinella F, Rollo F, Sacconi A, et al.
Biomark Res
. 2024 Mar;
12(1):37.
PMID: 38532476
No abstract available.
9.
Pulito C, Mori F, Sacconi A, Goeman F, Ferraiuolo M, Pasanisi P, et al.
Cell Discov
. 2024 Mar;
10(1):29.
PMID: 38480687
No abstract available.
10.
Liguoro D, Frigerio R, Ortolano A, Sacconi A, Acunzo M, Romano G, et al.
Cell Death Dis
. 2024 Mar;
15(3):208.
PMID: 38472212
Therapy of melanoma has improved dramatically over the last years thanks to the development of targeted therapies (MAPKi) and immunotherapies. However, drug resistance continues to limit the efficacy of these...